Procalcitonin in Hepatocellular Carcinoma

Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment

the value of serum procalcitonin in differentiation between bacterial infection and non infectious inflammation in febrile HCC patients following locoeregional treatment for HCC.

Inclusion Criteria:

1. - Hepatocellular carcinoma patients who will undergo TACE and/or radio-frequency.
2. - Fever more than 38C after 48 hours post intervention.

Exclusion Criteria:

1. HCC Patients who does not develop fever after intervention.
2. Proven infection elsewhere (e.g. UTI, chest infection..)